<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02669368</url>
  </required_header>
  <id_info>
    <org_study_id>01MgRo</org_study_id>
    <nct_id>NCT02669368</nct_id>
  </id_info>
  <brief_title>Magnesium Sulfate Effects on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy</brief_title>
  <official_title>Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <brief_summary>
    <textblock>
      This study aims to evaluate effects of magnesium sulfate on onset and duration of low dose
      rocuronium, intubation condition and surgical condition in patients undergoing laparoscopic
      cholecystectomy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2015</start_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The time of onset the action of Rocuronium</measure>
    <time_frame>Time from injection of Rocuronium till T1 suppression more than 95% up to 10 minutes.</time_frame>
    <description>by using the TOF watch nerve stimulator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The time at which Maximal suppression</measure>
    <time_frame>Time from the injection of Rocuronium to T1 maximal suppression time (TOF=0) up to an hour.</time_frame>
    <description>by using the TOF watch nerve stimulator</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reversal of Rocuronium</measure>
    <time_frame>Time from injection of Rocuronium till reversal of T1 (TOF=25%) around an hour after induction of anesthesia</time_frame>
    <description>by using the TOF watch nerve stimulator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation condition</measure>
    <time_frame>Within 10 minutes after induction of anesthesia</time_frame>
    <description>to score intubation condition on the basis of 6 items: Jaw relaxation, laryngoscopy, vocal cord position, moving of limbs, coughing &amp; change in heart rate.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical condition</measure>
    <time_frame>During surgery</time_frame>
    <description>to score a surgical condition according to 7 point likert scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Muscle Relaxation</condition>
  <arm_group>
    <arm_group_label>Standard dose Rocuronium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pretreatment of saline 100ml then giving Rocuronium 0.6 mg/kg at induction of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose Rocuronium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pretreatment of saline 100ml then giving Rocuronium 0.45 mg/kg at induction of anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose Rocuronium + Magnesium Sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pretreatment of Magnesium sulfate 30 mg/kg then giving Rocuronium 0.45 mg/kg at induction of anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium Sulfate</intervention_name>
    <description>Patients in each group receive Magnesium sulfate 30 mg/kg in 0.9% normal saline (total volume 100 ml) intravenously for 5 min before induction of anesthesia</description>
    <arm_group_label>Low dose Rocuronium + Magnesium Sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Patients in each group receive 0.9% normal saline (total volume 100 ml) alone intravenously for 5 min before induction of anesthesia</description>
    <arm_group_label>Standard dose Rocuronium</arm_group_label>
    <arm_group_label>Low dose Rocuronium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard dose Rocuronium</intervention_name>
    <description>0.6 mg/kg of Rocuronium given with induction of anesthesia</description>
    <arm_group_label>Standard dose Rocuronium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low dose Rocuronium</intervention_name>
    <description>0.45 mg/kg of Rocuronium given with induction of anesthesia</description>
    <arm_group_label>Low dose Rocuronium</arm_group_label>
    <arm_group_label>Low dose Rocuronium + Magnesium Sulfate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status 1 or 2.

          -  BMI of 25-34.9 kg/m2.

          -  Patients scheduled for laparoscopic cholecystectomy.

        Exclusion Criteria:

          -  Severe respiratory or cardiac disease.

          -  Hepatic or renal function impairment.

          -  Neuromuscular disease.

          -  Patients on medications affecting neuromuscular function.

          -  Patients with known allergy to the drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nawal Abdelaziz Gadelrab, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ola Mahmoud Wahba, Lecturer</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University Hospitals</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed Hamada Hamed Amin, Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University Hospitals</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assiut University Hospitals</name>
      <address>
        <city>Assiut</city>
        <zip>71121</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2016</study_first_submitted>
  <study_first_submitted_qc>January 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2016</study_first_posted>
  <last_update_submitted>January 29, 2016</last_update_submitted>
  <last_update_submitted_qc>January 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Hamada Hamed</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

